JP Morgan Maintains Overweight on CVS Health, Raises Price Target to $118
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $111 to $118.
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $111 to $118.